X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1670) 1670
Publication (82) 82
Book Review (62) 62
Book Chapter (32) 32
Conference Proceeding (3) 3
Web Resource (3) 3
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxcarbazepine (1549) 1549
humans (869) 869
carbamazepine (788) 788
epilepsy (613) 613
clinical neurology (591) 591
carbamazepine - analogs & derivatives (587) 587
male (525) 525
index medicus (489) 489
anticonvulsants - therapeutic use (475) 475
female (458) 458
antiepileptic drugs (454) 454
adult (377) 377
lamotrigine (364) 364
anticonvulsants (345) 345
epilepsy - drug therapy (337) 337
pharmacology & pharmacy (337) 337
carbamazepine - therapeutic use (326) 326
anticonvulsants - adverse effects (313) 313
middle aged (264) 264
neurosciences (233) 233
topiramate (232) 232
carbamazepine - adverse effects (224) 224
adolescent (222) 222
seizures (221) 221
double-blind (219) 219
gabapentin (202) 202
psychiatry (193) 193
neurology (191) 191
phenytoin (189) 189
child (179) 179
pharmacokinetics (177) 177
children (176) 176
animals (172) 172
anticonvulsants - pharmacokinetics (160) 160
aged (159) 159
treatment outcome (155) 155
levetiracetam (153) 153
efficacy (147) 147
analysis (146) 146
drugs (141) 141
anticonvulsants - pharmacology (138) 138
medicine & public health (138) 138
valproic acid (137) 137
dose-response relationship, drug (128) 128
anticonvulsants - administration & dosage (126) 126
monotherapy (126) 126
carbamazepine - blood (122) 122
carbamazepine - pharmacokinetics (119) 119
carbamazepine - pharmacology (116) 116
carbamazepine - administration & dosage (113) 113
anticonvulsants - blood (112) 112
drug interactions (110) 110
metabolites (106) 106
young adult (102) 102
drug therapy (101) 101
drug therapy, combination (101) 101
zonisamide (94) 94
valproate (93) 93
child, preschool (87) 87
partial seizures (86) 86
epilepsies, partial - drug therapy (85) 85
tolerability (84) 84
pregnancy (82) 82
chemistry, analytical (81) 81
retrospective studies (81) 81
therapy (81) 81
rats (80) 80
eslicarbazepine acetate (79) 79
tiagabine (79) 79
vigabatrin (78) 78
epilepsy - blood (76) 76
pediatrics (76) 76
care and treatment (74) 74
antiepileptic agents (73) 73
pharmacology/toxicology (70) 70
risk factors (69) 69
controlled clinical-trial (67) 67
double-blind method (65) 65
felbamate (65) 65
adults (64) 64
partial-onset seizures (64) 64
toxicology (63) 63
hyponatremia (62) 62
bipolar disorder (61) 61
safety (61) 61
sodium valproate (61) 61
mice (60) 60
previously untreated epilepsy (60) 60
seizures - drug therapy (60) 60
clinical trials as topic (59) 59
fructose - analogs & derivatives (59) 59
medicine, general & internal (57) 57
pharmacotherapy (57) 57
clinical trials (56) 56
neuropathic pain (56) 56
piracetam - analogs & derivatives (56) 56
valproic acid - therapeutic use (56) 56
anticonvulsant (54) 54
rats, wistar (53) 53
time factors (52) 52
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1532) 1532
German (54) 54
Spanish (52) 52
Italian (23) 23
Russian (13) 13
French (9) 9
Korean (6) 6
Turkish (6) 6
Portuguese (4) 4
Chinese (2) 2
Slovak (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Japanese (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
12/2011
Stevens-Johnson syndrome (SJS) is a rare immunologic reaction that may involve skin or various mucosal surfaces. The etiology may range from multiple... 
Stevens-Johnson syndrome | oxcarbazepine | Hypersensitivity
Web Resource
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 03/2019, Volume 75, Issue 3, pp. 381 - 392
PurposeOxcarbazepine (OXC) is an antiepileptic drug metabolised to active 10-monohydroxy derivative (MHD) following oral administration. There are no MHD... 
Oxcarbazepine | Population pharmacokinetics | Paediatric patient | Epileptic | Individualise | CLEARANCE | DRUG-INTERACTIONS | CARBAMAZEPINE | VALPROIC ACID | CLINICAL PHARMACOKINETICS | GENE POLYMORPHISMS | CHILDREN | PREDICTION | INFANTS | RESISTANCE | PHARMACOLOGY & PHARMACY | Anticonvulsants - pharmacokinetics | Oxcarbazepine - therapeutic use | Prospective Studies | Carbamazepine - analogs & derivatives | Humans | Anticonvulsants - therapeutic use | Epilepsy - metabolism | Genotype | Male | Oxcarbazepine - blood | Glucuronosyltransferase - genetics | Asian Continental Ancestry Group | Models, Biological | Epilepsy - drug therapy | Epilepsy - genetics | Female | ATP Binding Cassette Transporter, Subfamily B - genetics | Polymorphism, Single Nucleotide | Oxcarbazepine - pharmacokinetics | Child | Carbamazepine - blood | ATP Binding Cassette Transporter, Subfamily B, Member 2 - genetics | Medical research | Enzymes | Medical colleges | Metabolites | Healthcare industry software | Epilepsy | Medicine, Experimental | Single nucleotide polymorphisms | Chromosomes | Dosing | Immunoassay | Magnetohydrodynamics | Body weight | Oral administration | Data processing | Pharmacology | Single-nucleotide polymorphism | Antiepileptic agents | Dosage | Gene polymorphism | Patients | Mathematical models | Genetic factors | Pharmacokinetics | Bayesian analysis | Polymorphism | Index Medicus
Journal Article
Journal Article
NEUROLOGY, ISSN 0028-3878, 05/2011, Volume 76, Issue 20, pp. 1758 - 1765
Objective: To develop a scientifically sound and clinically relevant evidence-based guideline for the treatment of painful diabetic neuropathy (PDN). Methods:... 
OXCARBAZEPINE | PREGABALIN | AMITRIPTYLINE | POSTHERPETIC NEURALGIA | SODIUM VALPROATE | DOUBLE-BLIND | PERIPHERAL NEUROPATHY | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | CLINICAL NEUROLOGY | SYMPTOMATIC TREATMENT
Journal Article
Acta Pharmaceutica Sciencia, ISSN 1307-2080, 2017, Volume 55, Issue 2, pp. 79 - 94
Journal Article
NEUROLOGY, ISSN 0028-3878, 10/2008, Volume 71, Issue 15, pp. 1183 - 1190
Background: Trigeminal neuralgia (TN) is a common cause of facial pain. Purpose: To answer the following questions: 1) In patients with TN, how often does... 
BLIND | TRIAL | OXCARBAZEPINE | MULTIPLE-SCLEROSIS | FACIAL-PAIN | VASCULAR COMPRESSION | LAMOTRIGINE | NEUROVASCULAR COMPRESSION | CARBAMAZEPINE | EVOKED-POTENTIALS | CLINICAL NEUROLOGY
Journal Article
Clinical Medicine, Journal of the Royal College of Physicians of London, ISSN 1470-2118, 06/2018, Volume 18, Issue 3, pp. 256 - 258
Journal Article
Organic Process Research and Development, ISSN 1083-6160, 06/2014, Volume 18, Issue 6, pp. 810 - 815
This contribution describes the development of a ketoreductase enzyme over four rounds of directed evolution and the associated process development that... 
CHEMISTRY, ORGANIC | OXCARBAZEPINE | EPILEPSY | CHEMISTRY, APPLIED
Journal Article
ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA, ISSN 0102-0935, 11/2018, Volume 70, Issue 6, pp. 1754 - 1758
Different drugs are used in the treatment of epilepsy and, like other drugs, may induce the occurrence of adverse effects, some of them so severe that the drug... 
epilepsy | OXCARBAZEPINE | electroneuromyography | drugs | VETERINARY SCIENCES | polyradiculoneuropathy
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 07/2019, Volume 34, Issue 4, pp. 206 - 210
Journal Article
Neurologia, ISSN 0213-4853, 03/2014, Volume 29, Issue 2, pp. 94 - 101
Introduction: Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) and an analogue to carbamazepine (CBZ) and oxcarbazepine (OXC). In this study, we... 
Oxcarbazepine | Eslicarbazepine | Drug-resistant | Epilepsy | Carbamazepine
Journal Article
Chinese Journal of Contemporary Pediatrics, ISSN 1008-8830, 04/2015, Volume 17, Issue 4, pp. 414 - 419
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 08/2016, Volume 9, pp. 244 - 251
Journal Article
Pharmacogenomics, ISSN 1462-2416, 04/2018, Volume 19, Issue 6, pp. 547 - 552
Journal Article
MOLECULAR PHARMACOLOGY, ISSN 0026-895X, 11/2018, Volume 94, Issue 5, pp. 1256 - 1269
Neuropathic pain in patients carrying sodium channel gain-of-function mutations is generally refractory to pharmacotherapy. However, we have shown that... 
ACTION-POTENTIALS | OXCARBAZEPINE | DIAGNOSIS | PHENYTOIN | ROOT GANGLION NEURONS | SODIUM-CHANNELS | LIDOCAINE | PHENOTYPE | PHARMACOLOGY & PHARMACY | BINDING
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.